Feeds › Patents
Patents
New US patents granted to public companies.
About this data
- What it is
- The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
- Who files it
- The USPTO publishes each grant.
- How current
- Grants are published every Tuesday, and we collect them weekly.
- Worth knowing
- A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Patents granted per week, last 12 weeks
Latest patent grants
Showing: ticker RVMD
| Granted | Patent | Owner | Type | Source |
|---|---|---|---|---|
| Nov 10, 2026 | 12790351 Covalent Ras inhibitors and uses thereof | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Nov 3, 2026 | 12780841 Ras inhibitors | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Jun 23, 2026 | 12662707 MYC amplification drives resistance to pan-RAS inhibitors in pancreat… | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| May 12, 2026 | 12624053 Ras inhibitors | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Mar 24, 2026 | 12587381 Method and system for monitoring and controlling high risk substances | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Mar 3, 2026 | 12565476 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methy… | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Feb 10, 2026 | 12544448 C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Feb 3, 2026 | 12539305 Methods of treating cancer with an mTOR inhibitor | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Jan 20, 2026 | 12528807 Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3S,4S)… | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Nov 11, 2025 | 12465643 Ras inhibitors | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Sep 9, 2025 | 12409225 Ras inhibitors | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Sep 2, 2025 | 12403196 Ras inhibitors | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Aug 12, 2025 | 12384750 Ras inhibitors | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Jul 22, 2025 | 12365688 Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopy… | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Apr 22, 2025 | 12280113 Ras inhibitors | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Mar 25, 2025 | 12258366 Bicyclic heteroaryl compounds and uses thereof | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Mar 18, 2025 | 12252497 Ras inhibitors | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Jan 21, 2025 | 12202845 Ras inhibitors | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Jan 7, 2025 | 12187746 C26-linked rapamycin analogs as mTOR inhibitors | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
| Oct 22, 2024 | 12121522 Methods of treating cancer with an mTOR inhibitor | RVMD Revolution Medicines, Inc. | utility | Google Patents ↗ |
20 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:13 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances